Sunshine Biopharma Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Sunshine Biopharma Inc. on March 24, 2023. The Company is incorporated in Colorado and maintains its principal executive offices in Pointe-Claire, Quebec, Canada. Its common stock (SBFM) and warrants (SBFMW) are listed on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on a regulatory compliance matter regarding the Company's stock price.
Material Changes and Events
On March 24, 2023, the Company received a notification from Nasdaq stating it no longer meets the Minimum Bid Price Requirement under Rule 5550(a)(2). The closing bid price for the Company's common stock was below $1.00 for 30 consecutive trading days. This notification has no immediate effect on the listing status.
Outlook, Risks, and Management Commentary
- Compliance Period: The Company has 180 calendar days, until September 20, 2023, to regain compliance.
- Compliance Criteria: To cure the deficiency, the bid price must close at or above $1.00 per share for a minimum of 10 consecutive business days before September 20, 2023.
- Secondary Compliance Period: If the Company fails to regain compliance by the initial deadline, it may be eligible for an additional 180-day period. This requires meeting all other initial listing standards (excluding bid price) and potentially effecting a reverse stock split.
- Delisting Risk: If the Company cannot cure the deficiency or is deemed ineligible for an extension, Nasdaq may delist the securities.
- Management Action: The Company intends to actively monitor the bid price and consider available options to resolve the deficiency.
Key Facts for Investor Verification
- Verify the current trading price of SBFM to assess proximity to the $1.00 threshold.
- Monitor the Company's announcements regarding potential reverse stock splits or other capital structure changes.
- Track the 10 consecutive business day requirement for price recovery before the September 20, 2023 deadline.
- Review subsequent filings for updates on the Company's compliance status or potential delisting notices.